{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:05:51Z","timestamp":1774969551258,"version":"3.50.1"},"reference-count":49,"publisher":"The Pediatric Pharmacy Association","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"abstract":"<jats:p>\n          <jats:bold>OBJECTIVE:<\/jats:bold> To review the evidence describing the safety of ganciclovir and foscarnet in neonates in order to guide treatment for central nervous system or disseminated herpes simplex infections in cases of acyclovir shortage or resistance.<\/jats:p>\n        <jats:p>\n          <jats:bold>METHODS:<\/jats:bold> PubMed, Ovid Medline, and International Pharmaceutical Abstracts were searched using the thesaurus and text-word terms \u201cganciclovir\u201d and \u201cfoscarnet,\u201d with birth to 1 month age limits. Thirty-two eligible publications describing safety in neonates were identified.<\/jats:p>\n        <jats:p>\n          <jats:bold>RESULTS:<\/jats:bold> In 340 neonates treated for cytomegalovirus (CMV), life-threatening neutropenia (absolute neutrophil count &lt;0.5 \u00d7 10<jats:sup>9<\/jats:sup>\/L) was reported in 8.8% of patients following up to 12 months of ganciclovir administered intravenously. Neutropenia and thrombocytopenia occurred in 25.6% and 6.2% of neonates, respectively. Changes in serum creatinine concentration of &gt;0.2 mg\/dL occurred in &lt;1% of neonates. Hepatic transaminase increases or unspecified changes in liver function tests were reported in 6.2% of neonates with hyperbilirubinemia being observed in 3.5% of total neonates. Three out of four neonates receiving foscarnet for acyclovir-resistant herpes infection or CMV survived with minimal sequelae. Neither nephrotoxicity nor electrolyte or mineral imbalances were reported.<\/jats:p>\n        <jats:p>\n          <jats:bold>CONCLUSIONS:<\/jats:bold> Similar to what is seen in adolescents and adults, ganciclovir use in neonates is commonly associated with neutropenia, and the frequency of occurrence is comparable. The link between hepatotoxicity and ganciclovir should be interpreted with caution because of overlapping clinical manifestations of CMV. Only case reports are available describing foscarnet use in neonates, but adverse drug reactions were not observed. More research on these two agents is needed to draw conclusions about adverse drug reaction rates in the neonatal population.<\/jats:p>","DOI":"10.5863\/1551-6776-19.2.72","type":"journal-article","created":{"date-parts":[[2014,7,7]],"date-time":"2014-07-07T17:56:50Z","timestamp":1404755810000},"page":"72-82","source":"Crossref","is-referenced-by-count":7,"title":["Safety of Alternative Antiviral Agents for Neonatal Herpes Simplex Virus Encephalitis and Disseminated Infection"],"prefix":"10.5863","volume":"19","author":[{"given":"Yu","family":"Wang","sequence":"first","affiliation":[{"name":"College of Pharmacy, Roseman University of Health Sciences, South Jordan, Utah"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine P.","family":"Smith","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Roseman University of Health Sciences, South Jordan, Utah"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","reference":[{"issue":"RR-12","key":"i1551-6776-19-2-72-b1","series-title":"MMWR Recomm Rep.","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2010","volume":"59","year":"2010 Dec 17","unstructured":"Workowski\n              KA\n            , BermanS; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep.2010 Dec 17;59(RR-12):1\u2013110."},{"issue":"2","key":"i1551-6776-19-2-72-b2","series-title":"Pediatrics","first-page":"383","article-title":"Guidance on management of asymptomatic neonates born to women with active genital herpes lesions","volume":"131","year":"2013","unstructured":"Kimberlin\n              DW\n            , BaleyJ; Committee on Infectious Disease; Committee on Fetus and Newborn. Guidance on management of asymptomatic neonates born to women with active genital herpes lesions. Pediatrics. 2013;131(2):383\u2013386."},{"key":"i1551-6776-19-2-72-b3","series-title":"Red Book.","first-page":"398","article-title":"Summaries of infectious diseases - herpes simplex","year":"2012","unstructured":"Summaries of infectious diseases - herpes simplex. In: PickeringLK, BakerCJ, KimberlinDW, LongSS , eds. Red Book.Elk Grove Village, IL: American Academy of Pediatrics; 2012:398\u2013408."},{"issue":"4","key":"i1551-6776-19-2-72-b4","series-title":"J Perinatol","first-page":"290","article-title":"Persistence of herpes simplex virus DNA in cerebrospinal fluid of neonates with herpes simplex virus encephalitis","volume":"29","year":"2009","unstructured":"Mej\u00edas\n              A\n            , BustosR, ArduraMI, et al. Persistence of herpes simplex virus DNA in cerebrospinal fluid of neonates with herpes simplex virus encephalitis. J Perinatol. 2009;29(4):290\u2013296."},{"key":"i1551-6776-19-2-72-b5","article-title":"Current Drug Shortage Bulletin: acyclovir","unstructured":"Current Drug Shortage Bulletin: acyclovir. American Society of Health-System Pharmacists Web site. http:\/\/www.ashp.org\/menu\/DrugShortages\/CurrentShortages\/Bulletin.aspx?id=467. Updated May 30, 2013. Accessed May 30, 2013."},{"key":"i1551-6776-19-2-72-b6","article-title":"Red Book Online: antiviral recommendations for herpes simplex virus (HSV) and varicella zoster virus (VZV) infections in hospitalized pediatric patients during the intravenous acyclovir shortage","unstructured":"Red Book Online: antiviral recommendations for herpes simplex virus (HSV) and varicella zoster virus (VZV) infections in hospitalized pediatric patients during the intravenous acyclovir shortage. American Academy of Pediatrics Web site. http:\/\/aapredbook.aappublications.org\/site\/news\/acyclovir.xhtml. Updated May 27, 2013. Accessed May 30, 2013."},{"key":"i1551-6776-19-2-72-b7","series-title":"American Hospital Formulary Service Drug Information.","first-page":"783","article-title":"Ganciclovir","year":"2013","unstructured":"Ganciclovir. In: McEvoyGK, SnowEK, MillerJ , eds. American Hospital Formulary Service Drug Information.Bethesda, MD: American Society of Health-System Pharmacists; 2013:783\u2013794."},{"key":"i1551-6776-19-2-72-b8","series-title":"Pediatric and neonatal Lexi-drugs - ganciclovir","year":"2013","unstructured":"Pediatric and neonatal Lexi-drugs - ganciclovir. Hudson, OH: Lexicomp; 2013. http:\/\/www.lexi.com. Updated July 8, 2013. Accessed September 3, 2013."},{"key":"i1551-6776-19-2-72-b9","series-title":"Principles and Practice of Infectious Diseases.","first-page":"565","article-title":"Antiviral drugs","year":"2010","unstructured":"Aoki\n              FY\n            , HaydenFG, DolinR.\n          Antiviral drugs. In: MandellGL, BennettJE, DolinR , eds. Principles and Practice of Infectious Diseases.Philadelphia, PA: Churchill Livingstone; 2010:565\u2013610."},{"issue":"4","key":"i1551-6776-19-2-72-b10","series-title":"Blood","first-page":"1159","article-title":"Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation","volume":"99","year":"2002","unstructured":"Reusser\n              P\n            , EinseleH, LeeJ, et al. Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. Blood. 2002;99(4):1159\u20131164."},{"key":"i1551-6776-19-2-72-b11","series-title":"Basic & Clinical Pharmacology.","article-title":"Antiviral agents","year":"2012","unstructured":"Safrin\n              S.\n            \n          \n          Antiviral agents. In: KatzungBG, MastersSB, TrevorAJ , eds.Basic & Clinical Pharmacology.New York, NY: McGraw-Hill; 2012. http:\/\/www.accesspharmacy.com. Accessed June 10, 2013."},{"key":"i1551-6776-19-2-72-b12","series-title":"Pediatric and neonatal Lexi-drugs - foscarnet","year":"2013","unstructured":"Pediatric and neonatal Lexi-drugs - foscarnet. Hudson, OH: Lexicomp; 2013. http:\/\/www.lexi.com. Updated August 12, 2013. Accessed August 12, 2013."},{"issue":"11","key":"i1551-6776-19-2-72-b13","series-title":"Zhonghua Gan Zang Bing Za Zhi","first-page":"A14","article-title":"Foscarnet sodium for treatment in patients with severe chronic hepatitis B [in Chinese]","volume":"14","year":"2006","unstructured":"Yu\n              YY\n            , ZhangDZ, MiaoXH, et al. Foscarnet sodium for treatment in patients with severe chronic hepatitis B [in Chinese]. Zhonghua Gan Zang Bing Za Zhi. 2006;14(11):A14\u2013A16."},{"issue":"5","key":"i1551-6776-19-2-72-b14","series-title":"J Clin Endocrinol Metab","first-page":"1130","article-title":"Foscarnet-induced hypocalcemia and effects of foscarnet on calcium metabolism","volume":"72","year":"1991","unstructured":"Jacobson\n              MA\n            , GambertoglioJG, AweekaFT, et al. Foscarnet-induced hypocalcemia and effects of foscarnet on calcium metabolism. J Clin Endocrinol Metab. 1991;72(5):1130\u20131135."},{"issue":"1","key":"i1551-6776-19-2-72-b15","series-title":"Arch Intern Med.","first-page":"65","article-title":"Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial: studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group","volume":"155","year":"1995","unstructured":"Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial: studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. Arch Intern Med.1995;155(1):65\u201374."},{"issue":"1","key":"i1551-6776-19-2-72-b16","series-title":"Clin Pharmacol Ther","first-page":"15","article-title":"Linear single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections: NIAID Collaborative Antiviral Study Group","volume":"53","year":"1993","unstructured":"Trang\n              JM\n            , KiddL, GruberW, et al. Linear single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections: NIAID Collaborative Antiviral Study Group. Clin Pharmacol Ther. 1993;53(1):15\u201321."},{"issue":"9","key":"i1551-6776-19-2-72-b17","series-title":"Antimicrob Agents Chemother","first-page":"2202","article-title":"Population pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group","volume":"40","year":"1996","unstructured":"Zhou\n              XJ\n            , GruberW, DemmlerG, et al. Population pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group. Antimicrob Agents Chemother. 1996;40(9):2202\u20132205."},{"issue":"10","key":"i1551-6776-19-2-72-b18","series-title":"Ped Inf Dis J","first-page":"898","article-title":"Cytomegalovirus in peripheral blood leukocytes of infants with congenital or postnatal infection","volume":"15","year":"1996","unstructured":"Barbi\n              M\n            , BindaS, PrimacheV, Novelli. Cytomegalovirus in peripheral blood leukocytes of infants with congenital or postnatal infection. Ped Inf Dis J. 1996;15(10):898\u2013903."},{"issue":"suppl 3","key":"i1551-6776-19-2-72-b19","series-title":"J Clin Virol","first-page":"S81","article-title":"Human cytomegalovirus load in various body fluids of congenitally infected newborns","volume":"25","year":"2002","unstructured":"Halwachs-Baumann\n              G\n            , GenserB, PailerS, et al. Human cytomegalovirus load in various body fluids of congenitally infected newborns. J Clin Virol. 2002;25(suppl 3):S81\u2013S87."},{"issue":"2","key":"i1551-6776-19-2-72-b20","series-title":"Zhonqhua Shi Yan He Lin Chuang Bing Du Xue Za Zhi","first-page":"187","article-title":"Detection of human cytomegalovirus infection by FQ-PCR technique and its application in the diagnosis and treatment of HCMV infected children [in Chinese]","volume":"16","year":"2002","unstructured":"Chen\n              F\n            , HeZ, PanS, et al. Detection of human cytomegalovirus infection by FQ-PCR technique and its application in the diagnosis and treatment of HCMV infected children [in Chinese]. Zhonqhua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2002;16(2):187\u2013190."},{"issue":"2","key":"i1551-6776-19-2-72-b21","series-title":"J Infect Dis","first-page":"227","article-title":"Detection of cytomegalovirus (CMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving the central nervous system","volume":"191","year":"2005","unstructured":"Bradford\n              RD\n            , CloudG, LakemanAD, et al. Detection of cytomegalovirus (CMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving the central nervous system. J Infect Dis. 2005;191(2):227\u2013233."},{"issue":"5","key":"i1551-6776-19-2-72-b22","series-title":"J Obstet Gynecol Res","first-page":"619","article-title":"Fetal manifestations and poor outcomes of congenital cytomegalovirus infections: possible candidates for intrauterine antiviral treatments","volume":"33","year":"2007","unstructured":"Maruyama\n              Y\n            , SameshimaH, KamitomoM, et al. Fetal manifestations and poor outcomes of congenital cytomegalovirus infections: possible candidates for intrauterine antiviral treatments. J Obstet Gynecol Res. 2007;33(5):619\u2013623."},{"issue":"6","key":"i1551-6776-19-2-72-b23","series-title":"Clin Pharmacol Ther","first-page":"867","article-title":"Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation","volume":"81","year":"2007","unstructured":"Acosta\n              EP\n            , BrundageRC, KingJR, et al. Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation. Clin Pharmacol Ther. 2007;81(6):867\u2013872."},{"issue":"4","key":"i1551-6776-19-2-72-b24","series-title":"Zhonqhua Shi Yan He Lin Chuang Bing Du Xue Za Zhi","first-page":"361","article-title":"Detection of serum Th1 and Th2 cytokines and its significance in neonates with cytomegalovirus pneumonia [in Chinese]","volume":"21","year":"2007","unstructured":"Chen\n              ZG\n            , JiJZ, LiM, et al. Detection of serum Th1 and Th2 cytokines and its significance in neonates with cytomegalovirus pneumonia [in Chinese]. Zhonqhua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2007;21(4):361\u2013363."},{"issue":"1","key":"i1551-6776-19-2-72-b25","series-title":"Ir Med J","first-page":"17","article-title":"Cytomegalovirus infection in paediatric haemopoietic stem cell transplantation","volume":"101","year":"2008","unstructured":"Chong\n              AL\n            , ClintonF, BreatnachF, et al. Cytomegalovirus infection in paediatric haemopoietic stem cell transplantation. Ir Med J. 2008;101(1):17\u201321."},{"issue":"2","key":"i1551-6776-19-2-72-b26","series-title":"Ind Pediatr","first-page":"174","article-title":"Cytomegalovirus infection in six neonates","volume":"47","year":"2010","unstructured":"Yadav\n              SS\n            , NarulaG, NarayanS, et al. Cytomegalovirus infection in six neonates. Ind Pediatr. 2010;47(2):174\u2013175."},{"issue":"9","key":"i1551-6776-19-2-72-b27","series-title":"Arch Dis Child","first-page":"846","article-title":"Is lenticulostriated vasculopathy a sign of central nervous system insult in infants with congenital CMV infection?","volume":"96","year":"2011","unstructured":"Amir\n              J\n            , SchwarzM, LevyI, et al. Is lenticulostriated vasculopathy a sign of central nervous system insult in infants with congenital CMV infection?Arch Dis Child. 2011;96(9):846\u2013850."},{"issue":"4","key":"i1551-6776-19-2-72-b28","series-title":"Folia Med (Plovdiv)","first-page":"37","article-title":"Psychomotor development after ganciclovir selectively treated congenital and perinatal cytomegalovirus infection","volume":"54","year":"2012","unstructured":"Ivanov\n              IS\n            , PopovNT, MosheRI, et al. Psychomotor development after ganciclovir selectively treated congenital and perinatal cytomegalovirus infection. Folia Med (Plovdiv). 2012;54(4):37\u201344."},{"issue":"1","key":"i1551-6776-19-2-72-b29","series-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi","first-page":"57","article-title":"Different dosages ganciclovir treatment of symptomatic congenital cytomegalovirus infection in neonatal [in Chinese]","volume":"26","year":"2012","unstructured":"Hong-Bin\n              Z\n            , Feng-XianZ, Cai-PingG.\n          Different dosages ganciclovir treatment of symptomatic congenital cytomegalovirus infection in neonatal [in Chinese]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2012;26(1):57\u201359."},{"issue":"suppl 4","key":"i1551-6776-19-2-72-b30","series-title":"J Clin Virol","first-page":"S22","article-title":"Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system","volume":"46","year":"2009","unstructured":"Oliver\n              SE\n            , CloudGA, S\u00e1nchezPJ, et al. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol. 2009;46(suppl 4):S22\u2013S26."},{"issue":"6","key":"i1551-6776-19-2-72-b31","series-title":"Arch Dis Child Fetal Neonatal Ed","first-page":"F398","article-title":"Surveillance of congenital cytomegalovirus in the UK and Ireland","volume":"96","year":"2011","unstructured":"Townsend\n              CL\n            , PeckhamCS, TookeyPA.\n          Surveillance of congenital cytomegalovirus in the UK and Ireland. Arch Dis Child Fetal Neonatal Ed. 2011;96(6):F398\u2013F403."},{"issue":"9","key":"i1551-6776-19-2-72-b32","series-title":"Eur J Pediatr","first-page":"1061","article-title":"Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir","volume":"169","year":"2010","unstructured":"Amir\n              J\n            , WolfDG, LevyI.\n          Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir. Eur J Pediatr. 2010;169(9):1061\u20131067."},{"issue":"8","key":"i1551-6776-19-2-72-b33","series-title":"Zhongguo Dang Dai Er Ke Za Zhi","first-page":"641","article-title":"Comparison of therapeutic effect of different doses of ganciclovir for neonatal congenital cytomegalovirus infection","volume":"11","year":"2009","unstructured":"He\n              XR\n            , ChenPY, WangT, et al. Comparison of therapeutic effect of different doses of ganciclovir for neonatal congenital cytomegalovirus infection. Zhongguo Dang Dai Er Ke Za Zhi. 2009;11(8):641\u2013644."},{"issue":"4","key":"i1551-6776-19-2-72-b34","series-title":"J Laryngol Otol","first-page":"391","article-title":"Effect on hearing of ganciclovir therapy for asymptomatic congenital cytomegalovirus infection: four to 10 year follow up","volume":"123","year":"2009","unstructured":"Lackner\n              A\n            , AchamA, AlbornoT, et al. Effect on hearing of ganciclovir therapy for asymptomatic congenital cytomegalovirus infection: four to 10 year follow up. J Laryngol Otol. 2009;123(4):391\u2013396."},{"issue":"2","key":"i1551-6776-19-2-72-b35","series-title":"Scand J Infect Dis","first-page":"137","article-title":"Screening and diagnosis of congenital cytomegalovirus infection: a 5-y study","volume":"32","year":"2000","unstructured":"Halwachs-Baumann\n              G\n            , GenserB, DandaM, et al. Screening and diagnosis of congenital cytomegalovirus infection: a 5-y study. Scand J Infect Dis. 2000;32(2):137\u2013142."},{"issue":"6","key":"i1551-6776-19-2-72-b36","series-title":"J Infect Dis","first-page":"836","article-title":"Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease","volume":"197","year":"2008","unstructured":"Kimberlin\n              DW\n            , AcostaEP, S\u00e1nchezPJ.\n          Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis. 2008;197(6):836\u2013845."},{"key":"i1551-6776-19-2-72-b37","article-title":"Table for grading the severity of adult and pediatric adverse events","unstructured":"Table for grading the severity of adult and pediatric adverse events. National Institute of Allergy and Infectious Diseases Division of AIDS Regulatory Support Center Web site. http:\/\/rsc.tech-res.com\/Document\/safetyandpharmacovigilance\/Table_for_Grading_Severity_of_Adult_Pediatric_Adverse_Events.pdf. Updated August 2009. Accessed September 3, 2013."},{"issue":"9","key":"i1551-6776-19-2-72-b38","series-title":"Pediatr Infect Dis J","first-page":"782","article-title":"Ganciclovir therapy for congenital cytomegalovirus infection in six infants","volume":"24","year":"2005","unstructured":"Tanaka-Kitajima\n              N\n            , SugayaN, FutataniT, et al. Ganciclovir therapy for congenital cytomegalovirus infection in six infants. Pediatr Infect Dis J. 2005;24(9):782\u2013785."},{"issue":"1","key":"i1551-6776-19-2-72-b39","series-title":"J Pediatr","first-page":"16","article-title":"Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial","volume":"143","year":"2003","unstructured":"Kimberlin\n              DW\n            , LinCY, S\u00e1nchezPJ, et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003;143(1):16\u201325."},{"issue":"6","key":"i1551-6776-19-2-72-b40","series-title":"Pediatr Infect Dis J","first-page":"504","article-title":"Treatment of children with congenital cytomegalovirus infection with ganciclovir","volume":"22","year":"2003","unstructured":"Michaels\n              MG\n            , GreenbergDP, SaboDL, WaldER.\n          Treatment of children with congenital cytomegalovirus infection with ganciclovir. Pediatr Infect Dis J. 2003;22(6):504\u2013509."},{"issue":"12","key":"i1551-6776-19-2-72-b41","series-title":"Med Sci Monit","first-page":"CR815","article-title":"Cytomegalovirus disease in neonates and infants \u2013 clinical presentation, diagnostic and therapeutic problems \u2013 own experience","volume":"8","year":"2002","unstructured":"Liberek\n              A\n            , RytlewskaM, Szlagatys-SidorkiewiczA, et al. Cytomegalovirus disease in neonates and infants \u2013 clinical presentation, diagnostic and therapeutic problems \u2013 own experience. Med Sci Monit. 2002;8(12):CR815\u2013CR820."},{"issue":"5","key":"i1551-6776-19-2-72-b42","series-title":"J Infect Dis","first-page":"1080","article-title":"Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study","volume":"175","year":"1997","unstructured":"Whitley\n              RJ\n            , CloudG, GruberW, et al. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. J Infect Dis. 1997;175(5):1080\u20131086."},{"issue":"3","key":"i1551-6776-19-2-72-b43","series-title":"Arch Virol","first-page":"573","article-title":"Ganciclovir therapy for cytomegalovirus-associated liver disease in immunocompetent or immunocompromised children","volume":"142","year":"1997","unstructured":"Nigro\n              G\n            , KrzysztofiakA, BartmannU, et al. Ganciclovir therapy for cytomegalovirus-associated liver disease in immunocompetent or immunocompromised children. Arch Virol. 1997;142(3):573\u2013580."},{"issue":"2","key":"i1551-6776-19-2-72-b44","series-title":"J Pediatr","first-page":"318","article-title":"Ganciclovir therapy for symptomatic congenital cytomegalovirus infection in infants: a two-regimen experience","volume":"124","year":"1994","unstructured":"Nigro\n              G\n            , ScholzH, BartmannU.\n          Ganciclovir therapy for symptomatic congenital cytomegalovirus infection in infants: a two-regimen experience. J Pediatr. 1994;124(2):318\u2013322."},{"issue":"5","key":"i1551-6776-19-2-72-b45","series-title":"J Matern Fetal Neonatal Med","first-page":"325","article-title":"Foscarnet therapy for congenital cytomegalovirus liver fibrosis following prenatal ascites","volume":"15","year":"2004","unstructured":"Nigro\n              G\n            , SaliE, AnceschiMM, et al. Foscarnet therapy for congenital cytomegalovirus liver fibrosis following prenatal ascites. J Matern Fetal Neonatal Med. 2004;15(5):325\u2013329."},{"issue":"2","key":"i1551-6776-19-2-72-b46","series-title":"Scand J Infect Dis","first-page":"173","article-title":"A haemophagocytic lymphohistiocytosis (HLH)-like picture following breastmilk transmitted cytomegalovirus infection in a preterm infant","volume":"39","year":"2007","unstructured":"Knorr\n              B\n            , KesslerU, P\u00f6schlJ, et al. A haemophagocytic lymphohistiocytosis (HLH)-like picture following breastmilk transmitted cytomegalovirus infection in a preterm infant. Scand J Infect Dis. 2007;39(2):173\u2013176."},{"issue":"6","key":"i1551-6776-19-2-72-b47","series-title":"J Pediatr","first-page":"967","article-title":"Acyclovir-resistant neonatal herpes simplex virus infection of the larynx","volume":"124","year":"1994","unstructured":"Nyquist\n              AC\n            , RotbartHA, CottonM, et al. Acyclovir-resistant neonatal herpes simplex virus infection of the larynx. J Pediatr. 1994;124(6):967\u2013971."},{"issue":"11","key":"i1551-6776-19-2-72-b48","series-title":"Pediatr Infect Dis J","first-page":"1094","article-title":"Development of acyclovir-resistant herpes simplex virus early during the treatment of herpes neonatorum","volume":"20","year":"2001","unstructured":"Levin\n              MJ\n            , WeinbergA, LearyJJ, et al. Development of acyclovir-resistant herpes simplex virus early during the treatment of herpes neonatorum. Pediatr Infect Dis J. 2001;20(11):1094\u20131097."},{"issue":"5","key":"i1551-6776-19-2-72-b49","series-title":"Paediatr Drugs","first-page":"309","article-title":"Antivirals for cytomegalovirus infection in neonates and infants: focus on pharmacokinetics, formulations, dosing, and adverse events","volume":"11","year":"2009","unstructured":"Marshall\n              BC\n            , KochWC.\n          Antivirals for cytomegalovirus infection in neonates and infants: focus on pharmacokinetics, formulations, dosing, and adverse events. Paediatr Drugs. 2009;11(5):309\u2013321."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/19\/2\/article-p72.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/jppt\/article-pdf\/19\/2\/72\/2175065\/1551-6776-19_2_72.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/19\/2\/article-p72.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/19\/2\/article-p72.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:42:14Z","timestamp":1747356134000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/19\/2\/article-p72.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":49,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-19.2.72","relation":{},"ISSN":["1551-6776"],"issn-type":[{"value":"1551-6776","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}